Prostate Cancer Diagnostics and Therapy Market 2019-2024 | Global Industry Overview by Size, Share, Future Demand, Latest Research by Competitors, Segmentation and Regional Forecast

(The Express Wire via Comtex)

Prostate Cancer Diagnostics and Therapy Market share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

New research report on “Prostate Cancer Diagnostics and Therapy Market” 2019-2024 is a proficient and in-depth research offers an summary of the current market status, historic, and expected way forward for the Prostate Cancer Diagnostics and Therapy market. Prostate Cancer Diagnostics and Therapy market report on the world’s major regional market conditions, focusing on the main regions. Prostate Cancer Diagnostics and Therapy market report offers an extensive analysis of Prostate Cancer Diagnostics and Therapy industry to guide market players, new entrants and investors to get opinion of Prostate Cancer Diagnostics and Therapy industry.

Scope of the Report:

  • The prostate gland is located in the pelvis, below the bladder and in front of the rectum. Prostate cancer begins when normal cells in the prostate begin to multiply uncontrollably. The scope of the study is limited to revenue generated by various diagnostic and therapeutic products used in the management of benign prostatic hyperplasia, prostatic adenocarcinoma, and small cell carcinoma, among other types of prostate cancer.

Get a Sample Copy of the Report -https://www.industryresearch.co/enquiry/request-sample/14244650

Market Overview:

  • The prostate cancer diagnostics and therapy market is expected to register a CAGR of nearly 6.1% during the forecast period, 2019-2024.
  • - The major factor driving the growth of the market studied is aging population and high prevalence rate of prostate cancer. Prostate cancer is the second most common type of cancer in male population. About 80% of men who reach 80 years of age are diagnosed with it.
  • - As per the estimates provided by the American Cancer Society, in 2018, the United States is expected to witness over 164,690 new cases of prostate cancer, with over 29,430 related deaths. Nearly 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. One in every nine men is expected to be diagnosed with prostate cancer during his lifetime.
  • - In addition, according to the United States Census Bureau’s Statistics, the total number of people aged 65 and older exceeds 50 million as of 2017, and the number of elderly is projected to increase by almost 18 million during 2020-2030. The number of people aged 85 and older is expected to triple from an estimated 6 million of today to nearly 20 million, by 2060. The risk of developing prostate cancer increases significantly with age, and rise in geriatric population is one of the leading factors that contribute to the expansion of the mar

Prostate Cancer Diagnostics and Therapy market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. The Prostate Cancer Diagnostics and Therapy market 2019 report consists of the latest developments, market shares, and strategies employed by the major market players.

Top Key Players of Prostate Cancer Diagnostics and Therapy Market Report Are:

  • Ipsen SA
  • Bayer AG
  • Astellas Pharma Inc.
  • Abbvie Inc.
  • Dendreon Pharmaceuticals LLC
  • AstraZeneca PLC
  • Sanofi
  • Aventis
  • Tolmar Inc.
  • Koninklijke Philips NV
  • Hologic Inc.

Prostate Cancer Diagnostics and Therapy Market Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2024, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2024
  • Prostate Cancer Diagnostics and Therapy Market opportunities and recommendations for new investments

Inquire or Share Your Questions If Any Before the Purchasing This Report-https://www.industryresearch.co/enquiry/pre-order-enquiry/14244650

Key Market Trends:

The Prostate-specific Antigen (PSA) Testing Segment is Expected to Grow at Rapid Pace.

Prostate-specific Antigen (PSA) is a protein produced by prostate cells. Therefore, the PSA test is performed to diagnose prostate cancer (PCa) in men and for follow-up post treatment to check if the cancer relapses. PSA testing is an important tool for detecting prostate cancer, which measures the level of PSA in a man’s blood. Medicare and several private insurers provide coverage for an annual PSA test for all Medicare-eligible men aged 50 and older. The PSA testing is gaining popularity among clinicians and hospitals, owing to the increasing number of people being affected by prostate cancer. It has more market value in the countries with high prevalence rate (Western) and low prevalence rate (Asian), as PSA is used globally for the early detection/screening of prostate cancer.

PSA testing is anticipated to reduce the likelihood of death from prostate cancer. Refinements of the prostate-specific antigen (PSA) test have been developed to reduce the number of false positive results. Therefore, due to the rising prevalence of prostate cancer, the market is expected to witness high growth rate, over the forecast period.

United States is Expected to Retain the Largest Market Share During the Period of Forecast.

Prostate cancer is considered as one of the most common cancers among American men, and more than 60% of all prostate cancers are diagnosed in men older than 65. According to the American Cancer Society’s, 2019, there are about 174,650 new cases of prostate cancer accounting for 31,620 deaths. Hence, it is considered to have an early diagnosis of the condition. In case of the treatment, the early stages of prostate cancer are treated by radiation therapy and for the late stages, where it has spread beyond the prostate gland, hormone therapy, chemotherapy, and or immunotherapy treatments, are recommended. In the case of benign prostatic hyperplasia (BPH), resectoscopy is the major treatment procedure. Zytiga and Xtandi are the major therapeutics that are used for treatment. Zytiga is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). With promising pipeline drugs, such as Apalutamide, the market of therapeutics is expected to increase.

Prostate Cancer Diagnostics and Therapy Market Report Answers Following Questions:

  • What are the important RandD (Research and Development) factors and data identifications to responsible for rising market share?
  • What are future investment opportunities in the in Prostate Cancer Diagnostics and Therapy Devices landscape analyzing price trends?
  • Which are most dynamic companies with ranges and recent development within Prostate Cancer Diagnostics and Therapy Devices Market till 2024?
  • In what way is the market expected to develop in the forthcoming years?
  • What are the principle issues that will impact development, including future income projections?
  • What are market opportunities and potential risks associated with Prostate Cancer Diagnostics and Therapy Devices by analyzing trends?

Purchase this Report (Price 4250 USD for single user license) -https://www.industryresearch.co/purchase/14244650

Detailed TOC of Prostate Cancer Diagnostics and Therapy Market Report 2019-2024:

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Aging Population and High Prevalence Rate of Prostate Cancer
4.2.2 Innovation in Drugs and Developments in Genomics and Proteomics
4.2.3 Increasing Government Initiatives for Cancer Awareness
4.3 Market Restraints
4.3.1 High Cost of Prostate Cancer Drugs
4.3.2 Low Success Rate of Clinical Trials
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Benign Prostatic Hyperplasia
5.1.2 Prostatic Adenocarcinoma
5.1.3 Small Cell Carcinoma
5.1.4 Other Types
5.2 By Modality
5.2.1 Diagnosis
5.2.1.1 Tissue Biopsy
5.2.1.2 Transrectal Ultrasound
5.2.1.3 Clinical Laboratory Examination
5.2.1.3.1 Prostate-specific Antigen Testing
5.2.1.3.2 Urine Testing
5.2.1.4 Diagnostic Imaging
5.2.2 Treatment
5.2.2.1 Surgery
5.2.2.2 Radiation Therapy
5.2.2.3 Therapeutics
5.2.2.3.1 Hormone Therapy
5.2.2.3.2 Chemotherapy
5.2.2.3.3 Other Treatments
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ipsen SA
6.1.2 Bayer AG
6.1.3 Astellas Pharma Inc.
6.1.4 Abbvie Inc.
6.1.5 Dendreon Pharmaceuticals LLC
6.1.6 AstraZeneca PLC
6.1.7 Sanofi-Aventis
6.1.8 Tolmar Inc.
6.1.9 Koninklijke Philips NV
6.1.10 Hologic Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [email protected]

Our Other Reports:

Laptop Market Report 2019 Analysis by Market Players, Size, Share, Growth Rate, Opportunities, Drivers, and Risk Factor Forecast to 2025

Microswitch Market 2019 Share, Size, Regional Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by Forecast to 2025

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Prostate Cancer Diagnostics and Therapy Market 2019-2024 | Global Industry Overview by Size, Share, Future Demand, Latest Research by Competitors, Segmentation and Regional Forecast